169 related articles for article (PubMed ID: 17941284)
41. Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis.
Casale TB; Andrade C; Qu R
Allergy Asthma Proc; 1999; 20(3):193-8. PubMed ID: 10389553
[TBL] [Abstract][Full Text] [Related]
42. Intranasal phototherapy is more effective than fexofenadine hydrochloride in the treatment of seasonal allergic rhinitis: results of a pilot study.
Garaczi E; Boros-Gyevi M; Bella Z; Csoma Z; Kemény L; Koreck A
Photochem Photobiol; 2011; 87(2):474-7. PubMed ID: 21366599
[TBL] [Abstract][Full Text] [Related]
43. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
Jacobs R; Martin B; Hampel F; Toler W; Ellsworth A; Philpot E
Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
[TBL] [Abstract][Full Text] [Related]
44. Evidence for clinical safety, efficacy, and parent and physician perceptions of levocetirizine for the treatment of children with allergic disease.
Pampura AN; Papadopoulos NG; Spičák V; Kurzawa R
Int Arch Allergy Immunol; 2011; 155(4):367-78. PubMed ID: 21346367
[TBL] [Abstract][Full Text] [Related]
45. Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis.
Ohashi Y; Nakai Y; Murata K
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):600-5. PubMed ID: 16680932
[TBL] [Abstract][Full Text] [Related]
46. Brompheniramine maleate: a double-blind, placebo-controlled comparison with terfenadine for symptoms of allergic rhinitis.
Thoden WR; Druce HM; Furey SA; Lockhart EA; Ratner P; Hampel FC; van Bavel J
Am J Rhinol; 1998; 12(4):293-9. PubMed ID: 9740926
[TBL] [Abstract][Full Text] [Related]
47. Safety and tolerability of levocetirizine dihydrochloride in infants and children with allergic rhinitis or chronic urticaria.
Hampel F; Ratner P; Haeusler JM
Allergy Asthma Proc; 2010; 31(4):290-5. PubMed ID: 20819318
[TBL] [Abstract][Full Text] [Related]
48. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study.
Kawashima M; Tango T; Noguchi T; Inagi M; Nakagawa H; Harada S
Br J Dermatol; 2003 Jun; 148(6):1212-21. PubMed ID: 12828751
[TBL] [Abstract][Full Text] [Related]
49. Safety of fixed-dose loratadine/montelukast in subjects with allergic rhinitis.
Prenner BM; Lu S; Danzig MR
Allergy Asthma Proc; 2010; 31(6):493-8. PubMed ID: 21708061
[TBL] [Abstract][Full Text] [Related]
50. Assessment of the antiobstructive effect of fexofenadine on nasal allergy challenge in patients with seasonal allergic rhinitis.
Mösges R; Lehmacher W; Pasch N; Vent J
Asian Pac J Allergy Immunol; 2009 Dec; 27(4):181-90. PubMed ID: 20232572
[TBL] [Abstract][Full Text] [Related]
51. H1-antihistaminic activity of cetirizine and fexofenadine in allergic children.
Simons FE; J Semus M; Goritz SS; Simons KJ
Pediatr Allergy Immunol; 2003 Jun; 14(3):207-11. PubMed ID: 12787300
[TBL] [Abstract][Full Text] [Related]
52. Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukast-fexofenadine in patients of allergic rhinitis: A randomized, double-blind clinical trial.
Mahatme MS; Dakhale GN; Tadke K; Hiware SK; Dudhgaonkar SD; Wankhede S
Indian J Pharmacol; 2016; 48(6):649-653. PubMed ID: 28066101
[TBL] [Abstract][Full Text] [Related]
53. Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis.
Horak F; Stübner P; Zieglmayer R; Kavina A; De Vos C; Burtin B; Donnelly F
Int Arch Allergy Immunol; 2001 May; 125(1):73-9. PubMed ID: 11385291
[TBL] [Abstract][Full Text] [Related]
54. Cardiovascular safety of fexofenadine HCl.
Pratt CM; Mason J; Russell T; Reynolds R; Ahlbrandt R
Am J Cardiol; 1999 May; 83(10):1451-4. PubMed ID: 10335761
[TBL] [Abstract][Full Text] [Related]
55. [Serum sICAM-1 in patients suffering from allergic rhinitis treated with fexofenadine or fluticasone].
Górska-Ciebiada M; Ciebiada M; Zakrzewska A; Górski P; Grzelewska-Rzymowska I
Pneumonol Alergol Pol; 2004; 72(11-12):487-92. PubMed ID: 16329348
[TBL] [Abstract][Full Text] [Related]
56. [Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients].
Degonda M; Pichler WJ; Bircher A; Helbling A
Praxis (Bern 1994); 2002 Apr; 91(15):637-43. PubMed ID: 12014063
[TBL] [Abstract][Full Text] [Related]
57. Fexofenadine reduces nasal congestion in perennial allergic rhinitis.
Ciprandi G; Cosentino C; Milanese M; Mondino C; Canonica GW
Allergy; 2001 Nov; 56(11):1068-70. PubMed ID: 11703220
[TBL] [Abstract][Full Text] [Related]
58. Effectiveness and safety of fexofenadine, a new nonsedating H1-receptor antagonist, in the treatment of fall allergies.
Bronsky EA; Falliers CJ; Kaiser HB; Ahlbrandt R; Mason JM
Allergy Asthma Proc; 1998; 19(3):135-41. PubMed ID: 9642436
[TBL] [Abstract][Full Text] [Related]
59. Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study.
Okubo K; Gotoh M; Asako M; Nomura Y; Togawa M; Saito A; Honda T; Ohashi Y
Allergol Int; 2017 Jan; 66(1):97-105. PubMed ID: 27421817
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines.
Bensch GW; Nelson HS; Borish LC
Ann Allergy Asthma Immunol; 2002 May; 88(5):457-62. PubMed ID: 12027065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
